“[A]n estimated 1,399,180 people in the US are either living with, or are in remission from, leukemia, lymphoma or myeloma.” The Leukemia and Lymphoma Society,

Leukemia

New Cases

Prevalence

Deaths

Hodgkin (HL) and Non-Hodgkin (NHL) Lymphoma

New Cases

Prevalence

Survival

Myeloma

New Cases

Prevalence

Survival

Myelodysplastic Syndromes (MDS)

New Cases

Prevalence

The SEER program only recently began maintaining statistics for MDS. Prevalence statistics were not reported by SEER for MDS in 2019 at the time of this publication.

Survival

The SEER program only recently began maintaining statistics for MDS. Survival statistics were not reported by SEER for MDS in 2019 at the time of this publication.

Deaths

The SEER program only recently began maintaining statistics for MDS. Mortality statistics were not reported by SEER for MDS in 2019 at the time of this publication.

Myeloproliferative Neoplasms

New Cases

Survival

The SEER program only recently began maintaining statistics for MPNs. Survival statistics were not reported by SEER for MPNs in 2019 at the time of this publication.

Deaths

The SEER program only recently began maintaining statistics for MPNs. Mortality statistics were not reported by SEER for MPNs in 2019 at the time of this publication.

Blood disorders are causes of morbidity and mortality, affecting one in 76 people in the United States (US).